- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/06 - Antiglaucoma agents or miotics
Patent holdings for IPC class A61P 27/06
Total number of patents in this class: 1705
10-year publication summary
|
49
|
79
|
91
|
91
|
118
|
105
|
89
|
115
|
77
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2282 |
127 |
| Santen Pharmaceutical Co., Ltd. | 596 |
75 |
| Nicox S.A. | 147 |
27 |
| Senju Pharmaceutical Co., Ltd. | 225 |
21 |
| Kowa Company, Ltd. | 1220 |
20 |
| Regeneron Pharmaceuticals, Inc. | 4505 |
17 |
| The Regents of the University of California | 20355 |
16 |
| Alcon Research, Ltd. | 344 |
15 |
| Alcon, Inc. | 5602 |
14 |
| Daiichi Sankyo Company, Limited | 1877 |
13 |
| Ono Pharmaceutical Co., Ltd. | 425 |
12 |
| Bausch & Lomb Incorporated | 1085 |
10 |
| Eye Therapies LLC | 43 |
10 |
| Takeda Pharmaceutical Company Limited | 2710 |
9 |
| Novartis AG | 10494 |
8 |
| Astellas Pharma Inc. | 1050 |
8 |
| Dainippon Sumitomo Pharma Co., Ltd. | 176 |
8 |
| Japan Tobacco Inc. | 3554 |
8 |
| Novaliq GmbH | 170 |
8 |
| Rohto Pharmaceutical Co., Ltd. | 403 |
8 |
| Other owners | 1271 |